The increased expression of deoxynucleotidyltransferase terminal-interacting protein 1 (DNTTIP1) has been shown to facilitate NPC tumorigenesis by inhibiting the expression of the dual specificity phosphatase 2 (DUSP2) gene. The gene discussed is DNTTIP1; the disease is nasopharyngeal carcinoma.